Advertisement

Topics

FDA reviewing Herceptin biosimilar application

05:37 EDT 2 Aug 2017 | SmartBrief

The FDA is reviewing an application for approval of Teva Pharmaceutical Industries and Celltrion's CT-P6, a biosimilar versio -More

Original Article: FDA reviewing Herceptin biosimilar application

NEXT ARTICLE

More From BioPortfolio on "FDA reviewing Herceptin biosimilar application"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...